Comprehensive Snapshot of Anti-Snoring Devices Market Research Report, Including Regional and Country Analysis in Brief.
Industry: Healthcare
Delivery Timelines: Please Contact Sales
Published Date: April-2025
Format: PPT*, PDF, EXCEL
Number of Pages: 190
ID: PMRREP35318
The global anti-snoring devices market size is estimated to reach a size of US$ 1,617.4 Mn in 2025. It is predicted to rise at a CAGR of 7.4% to reach a value of US$ 2,670.6 Mn by 2032. The anti-snoring devices market is expanding steadily due to the increasing prevalence of sleep disorders such as obstructive sleep apnea (OSA) and patterns of chronic snoring. The need for effective remedies is on rise as people become more aware of the health hazards such as cardiovascular disease, hypertension, and daytime weariness.
According to a study conducted by Benjafield et al., over one billion people worldwide suffer from sleep apnea. Snoring is a common symptom of sleep apnea in upto 94% of patients. Anti-snoring products such as mandibular advancement devices (MADs), tongue retention devices (TRDs), CPAP machines, nasal dilators, and chin straps, with MADs are leading due to their effectiveness.
Adoption of AI-powered, app-connected anti-snoring devices is rapidly growing due to the demand for customized sleep monitoring and real-time modifications. These smart gadgets use machine learning algorithms and biometric sensors to monitor sleep patterns, snoring intensity, and breathing anomalies, then provide users with actionable insights via mobile applications. Wearable devices, smart pillows, and CPAP-integrated apps are becoming increasingly popular, with automated changes to increase airflow and eliminate snoring.
Key Industry Highlights:
|
Global Market Attribute |
Key Insights |
|
Anti-Snoring Devices Market Size (2025E) |
US$ 1,617.4 Mn |
|
Projected Market Value (2032F) |
US$ 2,670.6 Mn |
|
Global Market Growth Rate (CAGR 2025 to 2032) |
7.4% |
|
Historical Market Growth Rate (CAGR 2019 to 2024) |
6.0% |
The rise in global prevalence of obstructive sleep apnea (OSA) and habitual snoring primarily steers the demand. OSA is characterized by repeated airway blockages during sleep, affects millions of people worldwide, causing sleep disturbances and major health risks such as cardiovascular disease, high blood pressure, and diabetes. As people become increasingly aware of the health risks associated with OSA, as they seek effective counter remedies. In December 2024, Nitetronic launched Nitetronic Z6 Smart Anti-Snore Pillow a clinically proven anti-snoring pillow to reduce snoring. It has MEMS sensors and position sensors to detect and change head position. It has adjustable 9 cm to 13 cm height with memory foam pads.
For several patients using MAD and CPAP masks brings unpleasant experience. For instance, users complain about jaw pain that causes discomfort, and dental problems over time. This can inhibit frequent use and reduce long-term effectiveness. Similarly, CPAP masks, which are often used to treat obstructive sleep apnea, can be uncomfortable because of their bulky form, pressure, and the sensation of restricted airflow.
Users also experience skin discomfort, pressure sores, and difficulties to sleep. These challenges translate to patients discontinuing their treatment altogether. Moreover, the shortage of qualified professionals to capably diagnose and manage sleep apnea effectively limits the dependency on these devices.
The creation of adjustable and personalized mandibular advancement devices (MADs) represents a substantial opportunity in the anti-snoring device market. Traditional MADs frequently come in fixed sizes, which may not give the best fit for each user, resulting in discomfort and decreased performance.
Adjustable MADs provide a customizable fit, allowing users to change the device to better suit their jaw size and comfort level. This customization increases the device's performance, resulting in better treatment outcomes for people with diverse demands. For instance, in May 2024, Glidewell launched the EMA®, which is designed to promote deeper, more restful sleep by preventing snoring and relieving the symptoms of obstructive sleep apnea. Patients can easily change the distance of elastic straps in a customizable device.
Mandibular Advancement Devices (MADs) dominate the anti-snoring devices market, owing to their excellent efficacy in treating mild to moderate obstructive sleep apnea (OSA) and habitual snoring. These devices work by gradually moving the lower jaw forward, preventing airway collapse and minimizing snoring.
When compared to Continuous Positive Airway Pressure (CPAP) machines, MADs are more comfortable, non-invasive, and cost-effective, making them the preferred alternative for many patients. The increasing use of custom-fitted MADs designed by dental practitioners improves patient comfort and treatment efficacy.
Furthermore, developments in 3D printing technology and customizable designs are propelling innovation in this sector. For instance, in July 2023, Great Lakes partnered with OrthoApnea, the developer of the NOA mandibular-advancement device designed to treat obstructive sleep apnea and snoring.
The online sales channel is the leading distribution segment in the anti-snoring devices market, due to the growing preference for easy, direct-to-consumer (DTC) purchases. Consumers are increasingly turning to e-commerce platforms such as Amazon, Walmart, Alibaba, and Flipkart, which provide a diverse selection of products, customer reviews, discounts, and home delivery choices.
The rise of subscription-based models and trial programs for products such as mandibular advancement devices (MADs), nasal dilators, and smart anti-snoring devices drives online sales. With the rising internet penetration, and growing customer trust in e-commerce, online sales continue to outperform retail and hospital distribution channels.
North America dominates the global market, driven by a high prevalence of sleep disorders, including obstructive sleep apnea (OSA) and habitual snoring. Sleep apnea is becoming a global issue due to the rising prevalence of snoring is creating significant demand for anti-snoring devices. Sleep apnea affects around 170 million individuals in America yearly, according to ResMed. Approximately 10-15% of women and 15-30% of men are affected by sleep apnea in North America.
In July 2022, Smart Nora, a Canada-based startup, developed a unique device that detects snoring, gently adjusts the user's pillow to stimulate throat muscles, and reduces snoring without disturbing the user.
The U.S. is leading globally with the presence of leading manufacturers and availability of advanced devices for curing sleep apnea. As per the American Medical Association 2024, more than 30 million people suffer from sleep apnea in the U.S.
Asia Pacific is expanding rapidly due to increasing awareness of sleep disorders, rising disposable income, and improving healthcare infrastructure. Sleep apnea diagnosis and treatment adoption is increasing in countries such as China, India, Japan, and South Korea, owing to an aging population and urbanization.
According to a report published by ResMed in 2024, around 68% of Indians are aware of sleep apnea and 46% of them are diagnosed with sleep apnea. China’s anti-snoring devices market is evolving with rising number of people suffering from sleep apnea and growing adoption of anti-snoring devices for better quality of sleep leading to a better lifestyle. According to a Chinese consensus report 2024, around 176 million people in China have obstructive sleep apnea (OSA).
The Europe anti-snoring devices industry continues to grow, driven by rising awareness of sleep disorders, an aging population, and advances in sleep therapy solutions. EU regulatory standards and increasing healthcare expenditures are encouraging the adoption of clinically validated anti-snoring solutions. In August 2024, EU-funded researchers initiated a €15-million project involving 39 partner institutions and companies in Europe and Australia for development of smart wearables and advanced data analysis that could help bring relief to millions affected by sleep disorders.
The global anti-snoring devices market is competitive, with both established players and new entrants striving for market share by offering a range of products customized to diverse consumer needs. Their product offerings, technological advancements, and distribution channels differentiate key competitors in the market.
Leading firms concentrate on creating unique and effective solutions. Some players have progressed to smart devices, which include features such as mobile app connectivity, real-time tracking, and tailored changes to improve user comfort and compliance. Pricing strategies also drive competition, with some manufacturers offering low-cost alternatives to high-end gadgets.
|
Report Attribute |
Details |
|
Forecast Period |
2025 to 2032 |
|
Historical Data Available for |
2019 to 2024 |
|
Market Analysis |
US$ Million for Value |
|
Key Regions Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled in the Report |
|
|
Report Coverage |
|
|
Customization and Pricing |
Available upon request |
By Product Type
By Distribution Channel
By Region
To know more about delivery timeline for this report Contact Sales
The market size is set to reach US$ 2,670.6 Mn by 2032.
Increased cases of obstructive sleep apnea (OSA) and habitual snoring worldwide is the key driver for Anti-Snoring Devices Market demand.
In 2025, North America region is expected to dominate with 38.1% market share in the global Anti-Snoring Devices Market.
Among product segment, demand from Mandibular Advancement Devices (MADs) is expected to grow rapidly.
A few of the leading players in the market are ResMed, SomnoMed, ProSomnus Sleep Technologies, Vivos Therapeutics, Inc. among others.
